Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Ning-Ling Ge"'
Autor:
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji, Ling-Li Chen, Tian-Qiang Song, Wei Zhang, Zhi-Ming Zeng, Hua-Sheng Huang, Kui Wang, Lan-Qing Huang, Yong-Jun Chen, Yu-Chen Yang, Le-Du Zhou, Guo Long, Hai-Tao Zhao, Yun-Chao Wang, Ning-Ling Ge, Yi Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Pathologic complete response (pCR) following preoperative systemic therapy is associated with improved outcomes after subsequent liver transplant/resection in hepatocellular carcinoma (HCC). However, the relationship between radio
Externí odkaz:
https://doaj.org/article/d2e9b4fdc6104cccbc99fee0b861c2ac
Autor:
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract Advanced intrahepatic cholangiocarcinoma (ICC) has a dismal prognosis. Here, we report the efficacy and safety of combining toripalimab, lenvatinib, and gemcitabine plus oxaliplatin (GEMOX) as first-line therapy for advanced ICC. Thirty pati
Externí odkaz:
https://doaj.org/article/6f29477f8ecc4e3a86a2432ea36affb9
Autor:
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Dong Wu, Yuan Ji, Ning-Ling Ge, Ling-Li Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-11 (2021)
Abstract Background We evaluated organ-specific response rates (OSRRs) to first-line lenvatinib plus anti-PD-1 antibodies in patients with advanced hepatocellular carcinoma (HCC). Methods This retrospective analysis included Chinese patients with unr
Externí odkaz:
https://doaj.org/article/9bddf81339944a58b75b628e8468d6a6
Autor:
Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Yuan Ji, Ning-Ling Ge, Xu-Dong Qu, Lingli Chen, Wen-Kai Shi, Mei-Ling Li, Jin-Jin Zhu, Chang-Jun Tan, Zhao-You Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun
Publikováno v:
Liver Cancer, Pp 1-10 (2021)
Background: Combined therapy with tyrosine kinase inhibitors (TKIs) and anti-PD-1 antibodies has shown high tumor response rates for patients with unresectable hepatocellular carcinoma (HCC). However, using this treatment strategy to convert initiall
Externí odkaz:
https://doaj.org/article/c215b3559eae461aa196e42bf6ed209f
Autor:
Jing-huan Li, Xin Yin, Wen-shuai Fan, Lan Zhang, Rong-xin Chen, Yi Chen, Li-xin Li, Ning-ling Ge, Yu-hong Gan, Yan-hong Wang, Zheng-gang Ren
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPatients with hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (mPVTT) have poor prognosis. Promising systemic therapies, such as target therapies, have limited benefits. The purpose of this study is to retrospectively ev
Externí odkaz:
https://doaj.org/article/385a252f4b7d4f4db66afcf8993ab89e
Autor:
Tong-Chun Xue, Lan Zhang, Xiao-Yin Xie, Ning-Ling Ge, Li-Xin Li, Bo-Heng Zhang, Sheng-Long Ye, Zheng-Gang Ren
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96072 (2014)
The neutrophil-to-lymphocyte ratio (NLR) is a useful biomarker that reflects systemic inflammation responses. However, the prognostic value of the NLR in patients with primary liver cancer (PLC) remains controversial. We performed a meta-analysis of
Externí odkaz:
https://doaj.org/article/632a7530c2b64d8dbbbf8fcc8ab318bc
Autor:
Tong-Chun Xue, Ning-Ling Ge, Lan Zhang, Jie-Feng Cui, Rong-Xin Chen, Yang You, Sheng-Long Ye, Zheng-Gang Ren
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e109695 (2014)
The homeobox gene, goosecoid (GSC), is a transcription factor that participates in cell migration during embryonic development. Because cell migration during development has characteristics similar to cell invasion during metastasis, we evaluated the
Externí odkaz:
https://doaj.org/article/160d1cbf6a284066afc5587448d34469
Autor:
Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Bin Xu, Ning-Ling Ge, Yuan Ji, Xu-Dong Qu, Lingli Chen, Yi Chen, Mei-Ling Li, Jin-Jin Zhu, Zhao-You Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun
Publikováno v:
Annals of Surgical Oncology. 30:2791-2792
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed3627fd1069c9b5c9930d6ecce75be0
https://doi.org/10.1245/s10434-022-12653-3
https://doi.org/10.1245/s10434-022-12653-3
Autor:
Yan Wang, Zhenggang Ren, Xin Xu, Yi Chen, Jian-Feng Luo, Zhi-Ying Zhao, Yan-Hong Wang, Lan Zhang, Ning-Ling Ge, Xin Yin, Rongxin Chen, Mao-Pei Chen, Shu-Jung Hsu
Publikováno v:
Academic Radiology. 28:S157-S166
This study aimed to assess the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) with modified FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin) as an alternative treatment option in advanced hepatocellular carcinoma (HCC) patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c23357df01bed7ea9251c26e2d7f0f67
https://doi.org/10.1016/j.acra.2021.01.024
https://doi.org/10.1016/j.acra.2021.01.024
Autor:
Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Bin Xu, Ning-Ling Ge, Yuan Ji, Xu-Dong Qu, Lingli Chen, Yi Chen, Mei-Ling Li, Jin-Jin Zhu, Zhao-You Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun
Publikováno v:
Annals of surgical oncology.
Background Combined treatment with tyrosine kinase inhibitors (TKI) plus anti-PD-1 antibodies showed high anti-tumor efficacy and made conversion resection possible for patients with unresectable hepatocellular carcinoma (HCC). However, long-term sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467af266ddb557014e60ba311b07488e
https://pubmed.ncbi.nlm.nih.gov/36178565
https://pubmed.ncbi.nlm.nih.gov/36178565